Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/CSTONE-PHARMACEUTICALS-57946082/actualite/CStone-Pharmaceuticals-annonce-l-approbation-par-la-NMPA-du-sugemalimab-comme-traitement-de-premier-45527856/?utm_source=whatsapp&utm_medium=social&utm_campaign=share